Effective Late Stage Pathways For Biosimilar Products

February 16, 2018

In this presentation, ‘Effective Late Stage Pathways for Biosimilar Products’,  Dr. JingPing Yeo, outlines strategies to enhance operational efficiencies, optimize patient recruitment and retention and leverage data driven monitoring for data surveillance in Biosimilar studies.

Learn about ‘Effective Late Stage Pathways for Biosimilar Products’, in this presentation by PAREXEL’s  Dr. JingPing Yeo. Dr. Yeo outlines strategies to enhance operational efficiencies, optimize patient recruitment and retention and leverage data driven monitoring for data surveillance in Biosimilar studies.

View Presentation Here >

Previous Article
Accelerated Pathways & Commercial Consequences Forum & Findings
Accelerated Pathways & Commercial Consequences Forum & Findings

Read this presentation to find out more!

Next Article
Interactive eBook: Advanced RWE Learnings from the Field
Interactive eBook: Advanced RWE Learnings from the Field

This interactive ebook looks how you can create a strategy to prove your therapy’s value and get prescriber...

×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!